https://www.selleckchem.com/products/tl12-186.html
Currently no ideal alternative exists for heparin for cardiopulmonary bypass (CP. Dabigatran is a direct thrombin inhibitor for which a reversal agent exists. The primary end point of the study was to explore whether Dabigatran was an effective anticoagulant for 120 minutes of simulated CPB. The study was designed in 2 sequential steps. Throughout, human blood from healthy donors was used for each experimental step. Initially, increasing concentrations of Dabigatran were added to aliquots of fresh whole blood, and the anticoagulant e
Like
Comment
Share
